The Scientific World Journal

The Scientific World Journal / 2021 / Article

Research Article | Open Access

Volume 2021 |Article ID 6678059 |

Jitendra Pandey, Sushma Bhusal, Laxman Nepali, Maya Khatri, Rasmita Ramdam, Himal Barakoti, Paras Mani Giri, Dhakaraj Pant, Pramod Aryal, Rabindra Kumar Rokaya, Ravin Bhandari, "Anti-Inflammatory Activity of Artemisia vulgaris Leaves, Originating from Three Different Altitudes of Nepal", The Scientific World Journal, vol. 2021, Article ID 6678059, 8 pages, 2021.

Anti-Inflammatory Activity of Artemisia vulgaris Leaves, Originating from Three Different Altitudes of Nepal

Academic Editor: Ahmad Mansour
Received13 Dec 2020
Accepted16 Jun 2021
Published23 Jun 2021


This study aimed to evaluate and compare the in vivo chronic anti-inflammatory efficacy, from the ethyl acetate and ethanolic extracts of Artemisia vulgaris leaves, grown at three different altitudes in Nepal, by formalin-induced paw edema in Swiss albino mice. Edema was induced on the mice paw by administering 0.2% of formalin injection. Indomethacin was used as a standard drug at the concentration of 5 mg/kg of body weight. Ethyl acetate and ethanolic leaves extract, at the concentration of 200 mg/kg and 400 mg/kg, were used as test drugs. Standard drug and all the extracts were administered 30 min before formalin injection. The paw thickness was measured at 0, 1, 2, 3, 24, 48, and 72 hours after formalin injection, using a Vernier caliper. It was observed that both ethyl acetate and ethanolic extract from all the altitudes exhibited significant inhibition of paw edema () induced by formalin. Maximum activity was shown by 400 mg/kg of the plant leaf extract taken from the temperate zone, with 54.05% of paw edema inhibition, and it is almost similar to the inhibition of standard drug (56.75%). Moreover, the ethanolic extract was found to be more effective than ethyl acetate extract in all the plant samples. The results suggested that the anti-inflammatory effect of A. vulgaris leaves increases with an increase in altitudes and this plant can be used as a useful source of medicine to treat chronic inflammation.

1. Introduction

Inflammation is a localized protective response of mammalians cells/tissues towards allergic or chemical irritation, injury, and infection. Development of inflammation is associated with an increased level of various endogenous biological molecules, including nitric oxide (NO), reactive oxygen species (ROS), prostaglandin E2 (PGE2), and cytokines [1]. Depending upon the type of stimulus and efficacy of the inflammatory reaction in removing damaged tissue and harmful stimuli, inflammation may be acute or chronic in nature [2]. The primary defensive mechanism of macrophages during inflammation is characterized by the release of antimicrobial agents and cellular signaling molecules. However, the inflated release of cellular mediators through macrophages can lead to host cell damage, resulting in different diseases like rheumatism, encephalitis, pneumonia, esophagitis, cancer, heart problems, and fibrosis [36]. Currently, either narcotic such as opioid analgesic or nonsteroidal anti-inflammatory drugs like corticosteroids, salicylates have been used for the management of pain and inflammatory conditions. However, they exhibit serious adverse and toxic effects. Moreover, the overall cost for the development of a synthetic novel drug is very high. Therefore, screening of potential anti-inflammatory drugs having fewer adverse effects on natural plant sources is an alternative way to overcome this problem [5].

Artemisia vulgaris L., also known as mugwort, is a perennial long-stemmed shrub belonging to the family Compositae. It comprises hardy herbs and shrubs known for their volatile oils. It is native to temperate Europe, Asia, and northern Africa, but is also present in North America as an invasive weed [7]. In Ayurveda, A. vulgaris is a source of the snakebite antidote drug “nagdaun.” Traditionally aerial parts of A. vulgaris have been extensively used as anthelmintic, antiseptic, antispasmodic, antidiabetic, antiepileptic, vermicides, antiepilepsy, and antidepressant [8, 9]. The root has different uses, as a tonic for psychoneuroses, depression, autonomic neurosis, irritability, restlessness, insomnia, and anxiety. In China, A. vulgaris is used mostly for moxibustion. A. vulgaris is believed to stimulate blood flow and Qi at specific points on the skin, sometimes acupuncture points [10]. Different parts of A. vulgaris were reported to have broad biological activities such as antimicrobial, antihypertensive, antispasmodic and bronchodilator, hepatoprotective, antidepressant, xanthine oxidase inhibitor, and antioxidant [11]. The study on the regional variation of anti-inflammatory activity on this plant has not been conducted yet. Hence, this study aims to perform a comparative study of the in vivo anti-inflammatory activity of A. vulgaris obtained from three different geographical areas.

2. Materials and Methods

2.1. Chemicals Required

Indomethacin was purchased from S.R. Laboratories Pvt. Ltd., Kathmandu. Formaldehyde (Thermo Fisher scientific, India Pvt., Ltd., Mumbai), ethyl acetate, ethanol (Hangshu Kangyvan Chemical, China), and water were prepared in laboratory with distilled water plant.

2.2. Instruments

They are autoclave (S. M. Scientific Instruments (P) Ltd., Delhi), rotary evaporator (R-210/215, BUCHI Labortechnik AG, Switzerland), digital balance (ATX224, SHIMADZU Corporation, Philippines), grinder and distilled Water (DW) plant, hot air oven (S. M. Scientific Instruments (P) Ltd., Delhi), incubator (S. M. Scientific Instruments (P) Ltd.), refrigerator (GL-M492YLG), and sonicator (INDOSATI Scientific Instruments (P) Ltd., Delhi).

2.3. Plant Materials

The plant parts were collected from three different regions of Nepal, namely, Tamnagar, Rupandehi (tropical region, 350 m above sea level), Dhanchaur Arghakhanchi (subtropical region, 1829 m above the sea level), and Khalanga, Jumla (temperate region, 2518 m above sea level). Plant materials were taxonomically identified by Mr. Hom Nath Pathak, Prithivi Narayan Campus, Tribhuvan University, Nepal (identification letter number (FR-2015/26)) together with a literature comparison. The voucher specimen of the identified plants has been preserved in Crimson College of Technology, Pharmacognosy Lab (voucher specimen number: CCT-HRB-2018/169). Detailed information about the collection of plant material is given in Table 1.

Collection timePlant nameLocal nameParts usedCollection site

June 2018A. vulgarisTite patiLeavesRupandehi, Arghakhanchi, and Jumla

2.4. Preparation of Plant Extract

The plant parts were collected, cleaned, and converted to a fine powder after proper shade drying. A double cold maceration extraction procedure was performed by taking 200 g leaves of different regions, soaked with 1000 mL of ethyl acetate and ethanol in different conical flasks with occasional shaking for 72 hours. Liquids were strained and filtered. The process was repeated up to double maceration and the filtrate was mixed and then dried by using a rotary vacuum evaporator at a temperature of 40°C. The extract was placed in glass vials and extractive yields were determined. All the airtight vials were preserved in the refrigerator at 4°C until use.

2.5. Animals Used and Ethical Approval

To conduct animal experiments, Swiss albino mice of either sex weighing 25–35 g were used. All the mice were continuously provided with standard feed and water ad libitum. They were accommodated inside clean polypropylene maintaining uniform room temperature (22 ± 1°C), with a regular 12/12 h dark/light cycle until the experiment is completed. Before the experimental analysis, all the animals were acclimatized to laboratory conditions. Experimental procedures, animal handling, and care were conducted according to the official ethical guidelines of Nepal [1214]. All experimental mice were given 35% CO2 euthanasia after completing the analysis. The experimental protocol was authenticated by the Institutional Review Committee of Pokhara University (reference number: 130-089-076).

2.6. Acute Toxicity Studies

Acute toxicity in mice was investigated by adopting the Organization of Economic Cooperation and Development (OECD) guideline 425 [15]. A total of fifteen groups of Swiss Albino mice, each group containing five mice (n = 5), were formed. Among them, one was a normal control group and fourteen were test groups. The normal control group was supplied with normal saline and all test groups were provided with plant extract (500, 1000, and 2000 mg/kg, p.o.) at 10 mL/kg. Any toxic symptoms and mortality were monitored every 1 h for the next 6 h and total body weight was measured on days 1, 7, and 14 after treatment.

2.7. Anti-Inflammatory Activity Test
2.7.1. Administration of Test Sample

The test extract was given as suspension, in 0.5% of tween 80 solutions [16].

2.7.2. Preparation of Formalin Solution [16]

For this, 2 mL of formaldehyde was poured into a 100 mL volumetric flask and diluted up to exact 100 mL by using distilled water to prepare a 2% v/v fresh formalin solution.

2.7.3. Formalin-Induced Edema in Mice Paw

Anti-inflammatory activity was evaluated by adopting the previously established formalin-induced paw edema method [7, 1618]. Swiss albino mice were divided into 15 groups (5 animals in each group). Animals of all groups were injected with 0.2 mL of 2% v/v formalin, in the right hind paw, prepared by using distilled water.Group I animals (normal control) received 500 μL of 0.5% tween 80 only.Group II animals (formalin control) received distilled water p.o., 30 min prior to formalin injection.Group III, the standard reference group, was given p.o. an aqueous solution of indomethacin (5 mg/kg), 30 min prior to formalin injection.Groups IV and V received p.o. ethanolic extract of A. vulgaris of the tropical region, 200 mg/kg and 400 mg/kg of 0.5% tween 80, respectively.Groups VI and VII received ethyl acetate extract of A. vulgaris of the tropical region, 200 mg/kg and 400 mg/kg of 0.5% tween 80, respectively.Groups VIII and IX received p.o. ethanolic extract of A. vulgaris of the subtropical region, 200 mg/kg and 400 mg/kg of 0.5% tween 80, respectively.Groups X and XI received p.o. ethyl acetate extract of A. vulgaris of the subtropical region, 200 mg/kg and 400 mg/kg of 0.5% tween 80, respectively.Groups XII and XIII received p.o. ethanolic extract of A. vulgaris of the temperate region, 200 mg/kg and 400 mg/kg of 0.5% tween 80, respectively.Groups XIV and XV received p.o. ethyl acetate extract of A. vulgaris of the temperate region, 200 mg/kg and 400 mg/kg of 0.5% tween 80, respectively.

All the extracts were administered 30 min prior to formalin injection. The treatment was continued for three consecutive days at a fixed time but formalin was injected only on the first day. The paw volume of the mice was measured by using a vernier caliper and observed before and 1 h, 2 h, 3 h, 24 h, 48 h, and 72 h after formalin injection. The percentage inhibition of edema was calculated as follows:

2.8. Statistical Analysis

The calculation of the average edema for the anti-inflammatory was based on the expression of numerical data as mean ± SD and was evaluated by two-tailed Student’s t-test using Microsoft excel. The results obtained were compared with the control group. A was considered statistically significant.

3. Results

3.1. Extractive Yield Value

The extractive yield of A. vulgaris leaves from different climatic zones in ethyl acetate and ethanol is given in Table 2.

Serial numberPlantsLocationExtractive yield (%)
Ethanol extract (%)Ethyl acetate extract (%)

1A. vulgarisTamnar, Rupandehi6.649.21
2A. vulgarisDhanchaur, Arghakhanchi6.628.17
3A. vulgarisKhalanga, Jumla6.518.13

3.2. Acute Toxicity Test

After the continuous monitoring of the experimental animal, no toxicity was observed. None of the groups reported mortality after different doses (0.2, 0.4, 0.8, and 1 g/kg) of plant extract ingestion. Symptoms of toxicity such as sitting at the corner and paw licking were precipitated only at a dose of 1000 mg/kg body weight.

3.3. Anti-Inflammatory Activity

Table 3 and Figure 1 provoke the after-effect of anti-inflammatory property, by orally given ethyl acetate and ethanolic fractions of A. vulgaris at three different altitudes, in comparison to standard drug Indomethacin, from formalin-induced mouse paw edema. Injection of formalin into mice induced progressive paw edema achieving a maximum at 72 h. In the case of normal control group I, the thickness of the paw was found to be almost unchanged up to 72 h, whereas formalin control group II exhibited an increase in the thickness of the paw every hour and was significant at . In all groups treated with standard drug and plant extract, a successive decrease in paw thickness was observed immediately after the oral administration. The decrease in edema was proportional to the time increased. The anti-inflammatory activity of the ethanolic extract was found to be more effective than ethyl acetate extract from all plant samples at different altitudes in a dose-dependent manner. As shown in Figure 2, the highest activity was revealed by the ethanolic extract of A. vulgaris from the temperate region. From the time-course curve (at 48 and 72 h), AVTEAE treatment (400 mg/kg) displayed a remarkable effect () with maximal suppressive activity on inflammation by 54.05% at 48 and 72 h, which is almost similar to the standard drug Indomethacin. Besides, the administration of ethyl acetate fraction (400 mg/kg) at the same altitude exhibited moderate effect () with maximal suppressive activity on inflammation by 48.64% at 48 and 72 h. Indomethacin (5 mg/kg) performed the most significant and maximal anti-inflammatory effect by 56.76% at 48 and 72 h. Similarly, the ethanolic leaf extracts from the subtropical region (AVSTREE) and tropical region (AVTEE) displayed paw edema inhibition by 51.35% and 45.94%, respectively, at 48 and 72 h. The comparison of the anti-inflammatory response of A. vulgaris ethanolic and ethyl acetate extract, taken from three different altitudes, is illustrated in Figure 2 by plotting a bar diagram where all the extract are given at the dose of 400 mg/kg.

GroupsDose (ml/kg) p.o.Change in paw thickness (mm) ± SD (% inhibition)
0 hours1 hour2 hours3 hours24 hours48 hours72 hours

I-normal control500 µL1.5 ± 0.011.5 ± 0.021.5 ± 0.021.5 ± 0.011.5 ± 0.011.6 ± 0.021.6 ± 0.02

II-formalin control2 ml/kg2.4 ± 0.034.6 ± 0.054.6 ± 0.05,4.6 ± 0.05,4.0 ± 0.043.7 ± 0.043.7 ± 0.04

III-indomethacin5 mg/kg1.7 ± 0.04
29.16 ± 1.6%
3.0 ± 0.03
34.78 ± 0.6%
2.7 ± 0.08
41.30 ± 1.7%
2.6 ± 0.03
43.48 ± 0.6%
2.1 ± 0.05
47.50 ± 1.2%
1.6 ± 0.05
56.75 ± 1.3%
1.6 ± 0.06
56.75 ± 1.6%

IV-AVTREE200 mg/kg2.2 ± 0.05
8.33 ± 2.0%
4.3 ± 0.07
6.52 ± 1.5%
3.7 ± 0.05
19.56 ± 1.0%
3.2 ± 0.03
30.43 ± 0.6%
2.7 ± 0.06
32.50 ± 1.5%
2.2 ± 0.05
40.54 ± 1.3%
2.2 ± 0.07
40.54 ± 1.9%

V-AVTREE400 mg/kg2.0 ± 0.07
16.66 ± 2.9%
3.54 ± 0.04
23.04 ± 0.8%
3.2 ± 0.09
30.43 ± 1.9%
3.0 ± 0.06
34.78 ± 1.3%
2.5 ± 0.08
37.50 ± 2.0%
2.0 ± 0.05
45.94 ± 1.3%
2.0 ± 0.09
45.94 ± 2.4%

VI-AVTREAE200 mg/kg2.4 ± 0.08
0 ± 0.8%
4.5 ± 0.05
2.17 ± 1.0%
4.4 ± 0.06
4.35 ± 1.3%
3.4 ± 0.02
26.08 ± 0.4%
3.0 ± 0.07
25.0 ± 1.7%
2.5 ± 0.07
32.43 ± 1.9%
2.3 ± 0.08
37.83 ± 2.1%

VII-AVTREAE400 mg/kg2.2 ± 0.05
8.33 ± 2.0%
4.3 ± 0.02
6.52 ± 0.4%
3.5 ± 0.07
23.91 ± 1.5%
3.2 ± 0.06
30.43 ± 1.3%
2.8 ± 0.06
30.0 ± 1.5%
2.2 ± 0.06
40.54 ± 1.6%
2.2 ± 0.05
40.54 ± 1.3%

VIII-AVSTREE200 mg/kg2.0 ± 0.01
16.66 ± 0.4%
3.7 ± 0.03
19.56 ± 0.6%
3.2 ± 0.03
30.43 ± 0.6%
3.0 ± 0.07
34.78 ± 1.5%
2.5 ± 0.05
37.5 ± 1.2%
2.0 ± 0.07
45.94 ± 1.9%
2.0 ± 0.05
45.94 ± 1.3%

IX-AVSTREE400 mg/kg1.8 ± 0.02
25.0 ± 0.8%
3.3 ± 0.05
28.26 ± 1.0%
3.0 ± 0.03
34.78 ± 0.6%
2.8 ± 0.06
39.13 ± 1.3%
2.3 ± 0.04
42.5 ± 1.0%
1.8 ± 0.07
51.35 ± 1.9%
1.8 ± 0.03
51.35 ± 0.8%

X-AVSTREAE200 mg/kg2.0 ± 0.05
16.66 ± 2.0%
4.0 ± 0.07
13.04 ± 1.5%
3.5 ± 0.07
23.91 ± 1.5%
3.2 ± 0.03
30.43 ± 0.6%
2.7 ± 0.06
32.5 ± 1.5%
2.5 ± 0.08
32.43 ± 2.2%
2.1 ± 0.05
43.24 ± 1.3%

XI-AVSTREAE400 mg/kg1.8 ± 0.03
25.0 ± 1.2%
3.7 ± 0.04
19.56 ± 0.9%
3.2 ± 0.03
30.43 ± 0.6%
3.0 ± 0.03
34.78 ± 0.6%
2.5 ± 0.04
37.5 ± 1.00%
2.3 ± 0.09
37.84 ± 2.4%
2.0 ± 0.08
45.94 ± 2.2%

XII-AVTEE200 mg/kg1.9 ± 0.01
20.83 ± 0.4%
3.6 ± 0.07
21.74 ± 1.5%
3.2 ± 0.01
30.43 ± 0.2%
3.0 ± 0.02
34.78 ± 0.4%
2.5 ± 0.06
37.5 ± 1.5%
1.9 ± 0.06
48.64 ± 1.6%
1.9 ± 0.03
48.64 ± 0.8%

XIII-AVTEE400 mg/kg1.7 ± 0.06
29.16 ± 2.5%
3.2 ± 0.06,
30.43 ± 1.3%
2.9 ± 0.03
36.95 ± 0.6%
2.8 ± 0.04
39.13 ± 1.3%
2.2 ± 0.09
45.0 ± 2.2%
1.7 ± 0.05
54.05 ± 1.3%
1.7 ± 0.04
54.05 ± 1.1%

XIV-AVTEAE200 mg/kg2.0 ± 0.01
16.66 ± 0.4%
3.9 ± 0.02
15.22 ± 0.4%
3.4 ± 0.05
26.08 ± 1.0%
3.0 ± 0.03
34.78 ± 0.6%
2.6 ± 0.04
35.0 ± 1.0%
2.4 ± 0.04
35.13 ± 1.1%
2.0 ± 0.03
45.94 ± 0.8%

XV-AVTEAE400 mg/kg1.8 ± 0.02
25.0 ± 0.8%
3.5 ± 0.01
23.91 ± 0.2%
3.2 ± 0.02
30.43 ± 0.4%
2.9 ± 0.02
36.95 ± 0.4%
2.5 ± 0.03
37.5 ± 1.2%
2.1 ± 0.04
43.24 ± 1.1%
1.9 ± 0.04
48.64 ± 1.1%

All the results are expressed as mean ± SEM; n = 5. All the values are statistically significant at in comparison to formalin. AVTREE: A. vulgaris tropical ethanolic extract, AVTREAE: A. vulgaris tropical ethyl acetate extract, AVSTREE: A. vulgaris subtropical ethanolic extract, AVSTREAE: A. vulgaris subtropical ethyl acetate extract, AVTEE: A. vulgaris temperate ethanolic extract, and AVTEAE: A. vulgaris temperate ethyl acetate extract.

4. Discussion

Paw edema, induced in mice by administration of formalin, gives a close resemblance to human arthritis. Hence, it is considered as one of the most suitable techniques to screen possible drugs for chronic inflammation [16]. Formalin induces initial acute inflammatory infiltration into the temporomandibular joint (TMJ) of mice, which later develops into chronic infiltration. Furthermore, it results in persistent cellular proliferation and hyperplasia of the synovial lining and ultimately leads to the formation of villous areas [19]. The mechanism of formalin to induce inflammation is biphasic. In the first phase, its direct effect induces neurogenic pain whereas the second phase is associated with prominent inflammatory reactions governed by serotonin, bradykinin, prostaglandins, histamine, and cytokines [2]. Also, the substantial effect of the hormonal effect in formalin-induced paw edema has not been reported [5, 16], which allowed us to use the Swiss albino mice of either sex in this study. In this experiment, the formalin-induced paw edema model was employed to explore and compare the anti-inflammatory effect of A. vulgaris leaf at different altitudes. As shown in Table 3 and Figure 1, the administration of both ethyl acetate and ethanolic extract inhibited the progress of formalin-induced paw edema, depending upon the dose, showing the maximum effect at 48 and 72 h. In previous research, the therapeutic effect of A. vulgaris leaf against the acute and subacute inflammatory process has been proved by using carrageenan and cotton pellet granuloma induced inflammatory rat model, respectively [5, 7]. However, the study of its effect against chronic inflammation has not been done yet. The methanolic extract of aerial parts of A. vulgaris was found to inhibit carrageenan-induced rat paw edema by 74% at the concentration of 800 mg/kg after 3 h [7]. Similarly, methanolic leaf extract at the concentration of 400 mg/kg had exhibited 55.3% and 66.06% inhibition in the weight of wet and dry cotton pellets, respectively [7]. According to a previous report, A. vulgaris extract increases the activity of paraoxonase-1 enzyme. Paraoxonase-1 is a lipophilic antioxidant component, which prevents lipid peroxidation and its serum concentration is decreased during inflammation. Furthermore, it also reduces the increased level of serum TNF-α [20]. Diverse classes of bioactive compounds such as flavonoids, sesquiterpenoids, essential oils, tannins, phenols, and saponins present in A. vulgaris may produce an anti-inflammatory response by inhibiting the activity of prostaglandins synthesizing enzyme [7]. It has been verified that flavonoids can suppress the pronouncement of inducible nitric oxide synthase isomers, lipoxygenase, and cyclooxygenase, which are key enzymes, involved in the formation of the various inflammatory mediators [21]. Besides that, they can competitively bind to the catalytic site of the ATP to prevent the activity of the regulatory enzyme protein kinase and diminish the inflammatory response [22]. Saponins can exhibit their anti-inflammatory effects by preventing the biological effect of bradykinin or other inflammation mediators, along with the alteration of the prostaglandin synthesis pathway [23]. Similarly, terpenoids can inhibit inflammatory response by impeding the activity of tumor necrosis factor- (TNF-) α, cyclooxygenase enzymes, prostaglandin synthesis, cytokines (IL-2, IL-4, and IL-6), and inducible nitric oxide synthase enzymes [24]. Furthermore, the anti-inflammatory potency of tannins and sesquiterpenoids, which are abundantly present in A. vulgaris, is associated with the inhibitory effect on cyclooxygenase (COX-2) enzyme [25, 26]. Moreover, further advanced study at the molecular level is needed to establish the exact mechanism of anti-inflammatory action.

Major bioactive compounds present in methanolic and ethanolic extract of A. vulgaris are different derivatives of chlorogenic acid (dicaffeoylquinic acid isomers), flavonoids (derivatives of quercetin, rutin, and kaempferol), protocatechuic acid, malic acid, quinic acid, lignans, terpenoids (artemisinic acid glucoside derivatives) [27, 28], and so forth. The proportion of these bioactive compounds extracted by ethanol might be comparatively high as compared to ethyl acetate, due to higher polarity of ethanol than ethyl acetate [29]. This might be the possible reason for the higher anti-inflammatory effect of A. vulgaris ethanolic extract in comparison to its ethyl acetate extract.

No significant research work has been conducted, regarding the variation in phytochemical concentration and the pharmacological effect of A. vulgaris, growing among different altitudes. In our study, the lowest activity was reported from the plant of lower altitude and it increases with increasing altitude. Various factors such as genetic, phase of growth, soil condition, organogenesis, and anatomical parts may influence the quantitative composition of phytochemicals in medicinal plants and hence their pharmacological activities [30, 31]. Differences in weather conditions and the nature of the soil from which plants are collected (such as altitude variation) and also bring about the difference in phytochemical composition and concentration [3033]. Essential oils are major bioactive components present in all the species of the genus Artemisia. The quantity and quality of essential oils present in Artemisia species are always influenced by altitudes and geographical conditions [31]. According to Abad et al., 2012, in the plant Artemisia nilagirica grown at different altitudes of Himachal Pradesh India, the concentration of major essential oils present in it showed significant variation with change in altitudes. The concentration of camphor, borneol, and caryophyllene was maximal in higher, middle, and lower altitudes, respectively [34]. Potent anti-inflammatory compound camphor [35, 36] is present abundantly in A. vulgaris also [37]. The mechanism for the anti-inflammatory effect of camphor is due to its inhibitory action in the production of interleukin-4, interleukin-2, and TNF-α [38]. It may potentially suppress the production of proinflammatory cytokines induced by chemotactic agents like formyl-methionine-leucine-phenylalanine (fMLP), which activate multiple signaling cascades of inflammation [35, 39]. In a previous study, the essential oil content of Artemisia herba-alba was studied from four different altitudes; the maximum amount was reported from the plant sample taken at the highest altitudes [40]. In another study of the essential oil from Artemisia nilagirica, plants taken at 500 m altitude revealed α-thujone as a major compound, but it was present in a very small amount in the plants collected at higher altitudes. In contrast, L-linalool was a major component of the plants taken at 2000 m altitudes whereas it was detected in very low concentration in the case of low altitude plants [41]. L-Linalool is also present in A. vulgaris [36] and it is a potent anti-inflammatory compound. It is a competitive antagonist of N-methyl-D-aspartate (NMDA) receptor, which can attenuate behavioral hyperalgesia in rats and it may also prevent the possible action of glutamate release in response to harmful somatic stimuli [42]. For Artemisia absinthium, the cytotoxic effect of different plant parts at higher altitudes was found to be increased by 20%–30% in comparison to a lower altitude. The total amount of plant constituents varied from one altitude to another, and the pharmacological activities of such plants would change accordingly [43]. From all these facts, we can conclude that, in A. vulgaris, the concentration of anti-inflammatory compounds increases with altitudes which ultimately result in higher activity as compared to lower altitudes.

5. Conclusion

In this study, the potency of A. vulgaris leaves against chronic inflammation was justified using a valid animal experimental model. Moreover, plants grown at different altitudes exhibit pharmacological effects to a different extent, maybe due to their phytochemical variation. Easy availability and significant potency of A. vulgaris with minimum side effects can make this plant an appropriate candidate for the development of novel anti-inflammatory drugs. However, extensive investigation needed to be performed to confirm the effect of the extract via a preclinical and clinical trial with the elucidation of the exact mechanism at the molecular level.

Data Availability

All the data used to support the result of this research are available from Ravin Bhandari upon request.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors’ Contributions

Jitendra Pandey and Sushma Bhusal contributed equally to this work.


The authors would like to acknowledge Crimson College of Technology, Butwal-11, Devinagar, Rupandehi, Nepal, for technical support.


  1. Y.-C. Cho, A. Ju, B. R. Kim, and S. Cho, “Anti-inflammatory effects of Crataeva nurvala Buch. Ham. are mediated via inactivation of ERK but not NF-κB,” Journal of Ethnopharmacology, vol. 162, pp. 140–147, 2015. View at: Publisher Site | Google Scholar
  2. A. Arzi, S. Olapour, H. Yaghooti, and N. Sistani Karampour, “Effect of royal jelly on formalin induced-inflammation in rat hind paw,” Jundishapur Journal of Natural Pharmaceutical Products, vol. 10, no. 1, pp. 8–11, 2015. View at: Publisher Site | Google Scholar
  3. L. Boscá, M. Zeini, P. G. Través, and S. Hortelano, “Nitric oxide and cell viability in inflammatory cells: a role for NO in macrophage function and fate,” Toxicology, vol. 208, no. 2, pp. 249–258, 2005. View at: Google Scholar
  4. M. Fujihara, M. Muroi, K. I. Tanamoto, T. Suzuki, H. Azuma, and H. Ikeda, “Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex,” Pharmacology & Therapeutics, vol. 100, no. 2, pp. 171–194, 2003. View at: Google Scholar
  5. S. K. Afsar, K. Rajesh Kumar, J. Venu Gopal, and P. Raveesha, “Assessment of anti-inflammatory activity of Artemisia vulgaris leaves by cotton pellet granuloma method in wistar albino rats,” Journal of Pharmacy Research, vol. 7, no. 6, pp. 463–467, 2013. View at: Google Scholar
  6. L. Mayer and R. Bhikha, “The challenging response of physis to inflammation,” A Science of Medicine the Art of Care, pp. 1–63, 2013. View at: Google Scholar
  7. P. K. Ashok and K. Upadhyaya, “Evaluation of analgesic and anti-inflammatory activities of aerial parts of Artemisia vulgarisL. In experimental animal models,” Journal of Biologically Active Products from Nature, vol. 3, no. 1, pp. 101–105, 2013. View at: Publisher Site | Google Scholar
  8. M. Nigam, M. Atanassova, A. P. Mishra et al., “Bioactive compounds and health benefits of Artemisia species,” Natural Product Communications, vol. 14, no. 7, 2019. View at: Publisher Site | Google Scholar
  9. B. P. Pandey, R. Thapa, and A. Upreti, “Chemical composition, antioxidant and antibacterial activities of essential oil and methanol extract of Artemisia vulgaris and Gaultheria fragrantissima collected from Nepal,” Asian Pacific Journal of Tropical Medicine, vol. 10, no. 10, pp. 952–959, 2017. View at: Google Scholar
  10. J. D. Adams, C. Garcilia, and G. Garg, “Mugwort (Artemisia vulgaris, Artemisia douglasiana, Artemisia argyi) in the treatment of menopause, premenstrual syndrome, dysmenorrhea and attention deficit hyperactivity disorder,” Traditional Chinese Medicine, vol. 3, no. 3, pp. 116–123, 2015. View at: Google Scholar
  11. S. Malik, L. S. S. De Mesquita, C. R. Silva et al., “Chemical profile and biological activities of essential oil from Artemisia vulgaris L. cultivated in Brazil,” Pharmaceuticals, vol. 12, no. 2, pp. 1–10, 2019. View at: Publisher Site | Google Scholar
  12. D. R. Marasini, J. Pandey, L. P. Sharma et al., “A original article analgesic activity of bark and leaves of Ficus religiosa L. from Nepal,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 12, no. 7, pp. 32–35, 2020. View at: Publisher Site | Google Scholar
  13. R. Pantha, J. Pandey, N. Joshi et al., “Anti-urolithiatic property of Crataeva nurvala root and bark from Nepal on ethylene glycol induced urolithiatic mice,” Journal of Pharmaceutical Sciences and Research, vol. 12, pp. 658–662, 2020. View at: Google Scholar
  14. S. K. Pahari, S. P. Singh, M. P. Banmali, F. J. L. Thaler, and M. S. S. Rathour, Ethical Guidelines Forthe Care and Use of Animals in Health Research in Nepal, Nepal Health Research Council, Kathmandu, Nepal, 2005.
  15. OECD, Test No. 425: Acute Oral Toxicity: Up-And-Down Procedure, OECD, Paris, France, 2008.
  16. M. Singh, V. Kumar, I. Singh, V. Gauttam, and A. N. Kalia, “Anti-inflammatory activity of aqueous extract of Mirabilis jalapa Linn. leaves,” Pharmacognosy Research, vol. 2, no. 6, pp. 364–367, 2010. View at: Google Scholar
  17. S. Amdekar, P. Roy, V. Singh, A. Kumar, R. Singh, and P. Sharma, “Anti-inflammatory activity of lactobacillus on carrageenan-induced paw edema in male wistar rats,” International Journal of Inflammation, vol. 2012, Article ID 752015, 6 pages, 2012. View at: Publisher Site | Google Scholar
  18. S. R. Devkota, K. R. Paudel, K. Sharma et al., “Investigation of antioxidant and anti-inflammatory activity of roots of Rumex nepalensis,” World Journal of Pharmaceutical Sciences, vol. 4, no. 3, pp. 582–594, 2015. View at: Google Scholar
  19. A. C. Goulart, F. A. Correia, S. Dos, S. Sousa, and J. G. Luz, “Study of the inflammatory process induced by injection of carrageenan or formalin in the rat temporomandibular joint,” Pesqui Odontol Bras, vol. 19, no. 2, pp. 99–105, 2005. View at: Google Scholar
  20. W. H. El-Tantawy, “Biochemical effects, hypolipidemic and anti-inflammatory activities of Artemisia vulgaris extract in hypercholesterolemic rats,” Journal of Clinical Biochemistry and Nutrition, vol. 57, no. 1, pp. 33–38, 2015. View at: Google Scholar
  21. M. Tunon, M. Garcia-Mediavilla, S. Sanchez-Campos, and J. Gonzalez-Gallego, “Potential of flavonoids as anti-inflammatory agents: modulation of pro- inflammatory gene expression and signal transduction pathways,” Current Drug Metabolism, vol. 10, no. 3, pp. 256–271, 2009. View at: Publisher Site | Google Scholar
  22. JA. Manthey, “Biological properties of flavonoids pertaining to inflammation,” Microcirculation, vol. 7, pp. S29–S34, 2000. View at: Google Scholar
  23. A. Gepdiremen, V. Mshvildadze, H. Süleyman, and R. Elias, “Acute anti-inflammatory activity of four saponins isolated from ivy: alpha-hederin, hederasaponin-C, hederacolchiside-E and hederacolchiside-F in carrageenan-induced rat paw edema,” Phytomedicine, vol. 12, no. 6-7, pp. 440–444, 2005. View at: Publisher Site | Google Scholar
  24. V. Prakash, “Terpenoids as source of anti-inflammatory compounds,” Asian Journal of Pharmaceutical and Clinical Research, vol. 10, no. 3, pp. 68–76, 2017. View at: Google Scholar
  25. J. D. Adams, C. Garcia, and G. Garg, “Mugwort (Artemisia vulgaris, Artemisia douglasiana, Artemisia argyi) in the treatment of menopause, premenstrual syndrome, dysmenorrhea and attention deficit hyperactivity disorder,” Chinese Medicine, vol. 3, no. 3, pp. 116–123, 2012. View at: Publisher Site | Google Scholar
  26. L. Soon, P. Q. Ng, J. Chellian et al., “Therapeutic potential of Artemisia vulgaris: an insight into underlying immunological mechanisms,” Journal of Environmental Pathology, Toxicology and Oncology, vol. 38, no. 3, pp. 1–18, 2019. View at: Publisher Site | Google Scholar
  27. D. Melguizo-Melguizo, E. Diaz-De-Cerio, R. Quirantes-Piné, J. Švarc-Gajić, and A. Segura-Carretero, “The potential of Artemisia vulgaris leaves as a source of antioxidant phenolic compounds,” Journal of Functional Foods, vol. 10, pp. 192–200, 2014. View at: Google Scholar
  28. S.-J. Lee, H.-Y. Chung, I.-K. Lee, and I.-D. Yoo, “Isolation and identification of flavonoids from ethanol extracts of Artemisia vulgaris and their antioxidant activity,” Korean Journal of Food Science and Technology, vol. 31, no. 3, pp. 815–822, 1999. View at: Google Scholar
  29. A. Rajabian, M. H. Khayyat, S. A. Emami, Z. Tayarani-Najaran, R. R. Oskooie, and J. Asili, “Phytochemical evaluation and antioxidant activity of essential oil, and aqueous and organic extracts of Artemisia dracunculus,” Jundishapur Journal of Natural Pharmaceutical Products, vol. 12, no. 1, 2017. View at: Google Scholar
  30. E. Nemeth, “Essential oil composition of species in the genus Achillea,” Journal of Essential Oil Research, vol. 17, no. 5, pp. 501–512, 2005. View at: Google Scholar
  31. O. Gudaityte and P. R. Venskutonis, “Chemotypes of Achillea millefolium transferred from 14 different locations in Lithuania to the controlled environment,” Biochemical Systematics and Ecology, vol. 35, no. 9, pp. 582–592, 2007. View at: Google Scholar
  32. A. Poudel, J. Pandey, and H.-K. Lee, “Geographical discrimination in curcuminoids content of turmeric assessed by rapid UPLC-DAD validated analytical method,” Molecules, vol. 24, no. 9, p. 1805, 2019. View at: Google Scholar
  33. J. Pandey, T. Bastola, J. Tripathi et al., “Estimation of total quercetin and rutin content in Malus domestica of Nepalese origin by HPLC method and determination of their antioxidative activity,” Journal of Food Quality, vol. 2020, Article ID 8853426, 13 pages, 2020. View at: Publisher Site | Google Scholar
  34. M. J. Abad, L. M. Bedoya, L. Apaza, and P. Bermejo, “The Artemisia L. genus: a review of bioactive essential oils,” Molecules, vol. 17, no. 3, pp. 2542–2566, 2012. View at: Google Scholar
  35. S. E. Silva-Filho, F. M. Silva-Comar, L. A. M. Wiirzler et al., “Effect of camphor on the behavior of leukocytes in vitro and in vivo in acute inflammatory response,” Tropical Journal of Pharmaceutical Research, vol. 13, no. 12, pp. 2031–2037, 2014. View at: Google Scholar
  36. S. S. Ghori, M. I. Ahmed, M. Arifuddin, and M. S. Khateeb, “Evaluation of analgesic and anti-inflammatory activities of formulation containing camphor, menthol and thymol,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 8, no. 1, pp. 271–274, 2016. View at: Google Scholar
  37. P. Blagojević, N. Radulović, R. Palić, and G. Stojanović, “Chemical composition of the essential oils of Serbian wild-growing Artemisia absinthium and Artemisia vulgaris,” Journal of Agricultural and Food Chemistry, vol. 54, no. 13, pp. 4780–4789, 2006. View at: Publisher Site | Google Scholar
  38. A. Vonapart, A. Karioti, M. C Recio et al., “Effects of terpenoids from salvia willeana in delayed-type hypersensitivity, human lymphocyte proliferation and cytokine production,” Natural Product Communications, vol. 3, pp. 1953–1958, 2008. View at: Publisher Site | Google Scholar
  39. M. A. Cassatella, “The production of cytokines by polymorphonuclear neutrophils,” Immunology Today, vol. 16, no. 1, pp. 21–26, 1995. View at: Google Scholar
  40. B. Behtari, F. Gholami, K. A. Khalid, G. D. Tilaki, and R. Bahari, “Effect of growth stages and altitude on artemisia herba-alba asso essential oil growing in Iran,” Journal of Essential Oil Bearing Plants, vol. 15, no. 2, pp. 307–313, 2012. View at: Google Scholar
  41. R. Badoni, D. K. Semwal, and U. Rawat, “Altitudinal variation in the volatile constituents of Artemisia nilagirica,” International Journal of Essential Oil Therapeutics, vol. 3, no. 2–3, pp. 66–68, 2009. View at: Google Scholar
  42. A. T. Peana, P. S. D’Aquila, F. Panin, G. Serra, P. Pippia, and M. D. L. Moretti, “Anti-inflammatory activity of linalool and linalyl acetate constituents of essential oils,” Phytomedicine, vol. 9, no. 8, pp. 721–726, 2002. View at: Google Scholar
  43. B. Gordanian, M. Behbahani, J. Carapetian, and M. Fazilati, “Cytotoxic effect of Artemisia absinthium L. grown at two different altitudes on human breast cancer cell line MCF7,” Research in Medicine, vol. 36, no. 3, pp. 124–131, 2012. View at: Google Scholar

Copyright © 2021 Jitendra Pandey et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.